NASDAQ:VRNA Verona Pharma (VRNA) News Today $21.10 +0.41 (+1.98%) (As of 06/8/2023 ET) Add Compare Share Share Today's Range$20.38▼$21.5450-Day Range$19.41▼$23.4352-Week Range$3.85▼$26.44Volume247,193 shsAverage Volume561,042 shsMarket Capitalization$1.67 billionP/E RatioN/ADividend YieldN/APrice Target$29.33 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Get Verona Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address VRNA Media Mentions By Week VRNA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRNA News Sentiment▼0.400.50▲Average Medical News Sentiment VRNA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRNA Articles This Week▼43▲VRNA Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTruist Securities Maintains Verona Pharma Plc - ADR (VRNA) Buy Recommendationmsn.com - June 7 at 11:48 PMTruist Financial Raises Verona Pharma (NASDAQ:VRNA) Price Target to $32.00americanbankingnews.com - June 7 at 8:34 AMVerona Pharma (VRNA) Gets a Buy from H.C. Wainwrightmarkets.businessinsider.com - June 2 at 8:35 AMCommonwealth Equity Services LLC Invests $326,000 in Verona Pharma plc (NASDAQ:VRNA)marketbeat.com - May 31 at 4:38 AMEnvestnet Asset Management Inc. Grows Holdings in Verona Pharma plc (NASDAQ:VRNA)marketbeat.com - May 29 at 4:00 AMVerona Pharma: Poised For A Breakthrough In COPD Treatment Amidst Favorable Financial Positionmsn.com - May 28 at 10:05 AMVerona Pharma plc (NASDAQ:VRNA) Receives Average Rating of "Buy" from Brokeragesamericanbankingnews.com - May 24 at 2:46 AMVerona Pharma (NASDAQ:VRNA) Trading Down 3.6%americanbankingnews.com - May 19 at 8:28 AMVerona Pharma plc (NASDAQ:VRNA) Given Average Rating of "Buy" by Brokeragesmarketbeat.com - May 19 at 3:50 AMVerona Pharma: Revolutionizing COPD With First Triple Mechanism Inhaled Drugseekingalpha.com - May 18 at 6:51 PMVerona Pharma plc (NASDAQ:VRNA) Director Sells $1,780,800.00 in Stockamericanbankingnews.com - May 18 at 4:38 AMOrbimed Advisors Llc Sells 359,713 Shares of Verona Pharma plc (NASDAQ:VRNA) Stockamericanbankingnews.com - May 17 at 4:46 AMMassive Insider Trade At Verona Pharmabenzinga.com - May 16 at 12:44 PMWedbush Weighs in on Verona Pharma plc's Q2 2023 Earnings (NASDAQ:VRNA)americanbankingnews.com - May 16 at 1:26 AMVerona Pharma plc (NASDAQ:VRNA) Forecasted to Post Q2 2023 Earnings of ($0.27) Per Sharemarketbeat.com - May 15 at 1:11 AMVerona Pharma plc (VRNA) Q1 2023 Earnings Call Transcriptseekingalpha.com - May 13 at 10:11 AMAnalysts Offer Predictions for Verona Pharma plc's FY2027 Earnings (NASDAQ:VRNA)marketbeat.com - May 12 at 10:58 AMVerona Pharma plc (NASDAQ:VRNA) Short Interest Up 21.8% in Aprilmarketbeat.com - May 12 at 8:21 AMCanaccord Genuity Maintains Verona Pharma Plc - ADR (VRNA) Below Average Recommendationmsn.com - May 12 at 1:55 AMHC Wainwright & Co. Reiterates Verona Pharma Plc - ADR (VRNA) Buy Recommendationmsn.com - May 11 at 8:55 PMVerona Pharma (NASDAQ:VRNA) Shares Gap Up to $21.87americanbankingnews.com - May 11 at 7:13 AMVerona Pharma plc: Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - May 9 at 8:54 AMVerona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - May 9 at 8:54 AMInsider Selling: Verona Pharma plc (NASDAQ:VRNA) General Counsel Sells $207,370.08 in Stockamericanbankingnews.com - May 6 at 5:48 AMVerona Pharma plc (NASDAQ:VRNA) Insider Sells $199,753.92 in Stockamericanbankingnews.com - May 6 at 5:48 AMKathleen A. Rickard Sells 28,752 Shares of Verona Pharma plc (NASDAQ:VRNA) Stockamericanbankingnews.com - May 6 at 5:48 AMVerona Pharma plc (NASDAQ:VRNA) CEO Sells $1,175,282.88 in Stockamericanbankingnews.com - May 6 at 4:50 AMVerona Pharma plc (NASDAQ:VRNA) CFO Mark W. Hahn Sells 455,528 Shares of Stockamericanbankingnews.com - May 4 at 7:10 AMVerona Pharma to Present Expanded Analyses of Positive Phase 3 ENHANCE Studies in COPD in Multiple Presentations at ATS 2023finance.yahoo.com - May 2 at 2:08 AMVerona Pharma plc (NASDAQ:VRNA) Shares Bought by AlphaCentric Advisors LLCmarketbeat.com - May 1 at 12:13 PMVerona Pharma plc (NASDAQ:VRNA) Receives $29.33 Average Price Target from Brokeragesamericanbankingnews.com - April 27 at 1:22 AMVerona Pharma to Report First Quarter 2023 Financial Results and Provide Corporate Updatefinance.yahoo.com - April 25 at 2:38 AMDekaBank Deutsche Girozentrale Invests $504,000 in Verona Pharma plc (NASDAQ:VRNA)marketbeat.com - April 24 at 5:08 AMVerona Pharma plc (NASDAQ:VRNA) Receives Consensus Recommendation of "Buy" from Analystsmarketbeat.com - April 24 at 4:17 AMVerona Pharma (NASDAQ:VRNA) Trading Up 6.4%americanbankingnews.com - April 21 at 7:37 AMTelecom, Pharma Stocks Lead European Equities Lower in Thursday Tradingmsn.com - April 20 at 12:14 PMVerona Pharma: Ensifentrine Vs. Dupixent, Ensifentrine Is A Breath Of Fresh Airseekingalpha.com - April 16 at 12:45 PMWhen Will Verona Pharma plc (NASDAQ:VRNA) Breakeven?finance.yahoo.com - April 11 at 7:43 AMHC Wainwright & Co. Reiterates Verona Pharma (VRNA) Buy Recommendationmsn.com - April 10 at 9:19 PMNuance Pharma Announces Dosing of First Patient in ENHANCE – China Phase 3 Trial for COPDfinance.yahoo.com - April 10 at 8:49 AMAnalysts Set Verona Pharma plc (NASDAQ:VRNA) PT at $29.33americanbankingnews.com - April 2 at 1:14 AMMoody Aldrich Partners LLC Lowers Position in Verona Pharma plc (NASDAQ:VRNA)marketbeat.com - March 31 at 2:34 PMTop Healthcare Stocks for April 2023finance.yahoo.com - March 30 at 6:05 PMVerona Pharma plc (NASDAQ:VRNA) Receives Average Recommendation of "Buy" from Analystsmarketbeat.com - March 30 at 4:35 AMBuy Verona Pharma For Its Strong COPD Contenderseekingalpha.com - March 28 at 12:18 PMVerona's Ensifentrine: A Promising Novel Treatment For COPD Patientsseekingalpha.com - March 27 at 10:16 AMBTIG Research Boosts Verona Pharma (NASDAQ:VRNA) Price Target to $31.00americanbankingnews.com - March 23 at 3:12 AMVerona Pharma PLC American Depositary Share (VRNA) Stock Moves -0.46%: What You Should Knowfinance.yahoo.com - March 22 at 8:45 PMVerona Pharma plc to Post Q3 2023 Earnings of ($0.32) Per Share, HC Wainwright Forecasts (NASDAQ:VRNA)marketbeat.com - March 15 at 7:47 AM4 Analysts Have This to Say About Verona Pharmamsn.com - March 13 at 7:25 PM Get Verona Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IRWD News RCKT News XNCR News FGEN News KDNY News SLRN News AMLX News GERN News ZNTL News DICE News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:VRNA) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.